Following the publication of an article in the Dutch newspaper Nieuwe Rotterdamsche Courant Handelsblad (NRC) concerning an impurity (4-chloroaniline) in the active substance paracetamol manufactured by a specific company which holds a certificate of suitability, the EDQM is actively working with the company and other stakeholders to better understand the potential impact of this impurity and the extent of the issue.
null EDQM’s actions to evaluate impact of the detection of an impurity in the active substance paracetamol
EDQM Strasbourg, France 10/07/2020
- Diminuer la taille du texte
- Augmenter la taille du texte
- Imprimer la page
- Imprimer en PDF
trainings and events